Track topics on Twitter Track topics that are important to you
Novartis will use a priority review voucher to expedite review of the treatment that could hit blockbuster status within two years of launching.
Original Article: Novartis Eyes Late 2019 Launch for Wet AMD DrugNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...